Figure 3From: Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers Plasma sVEGFR2 ratio to baseline in metastatic RCC patients treated with sunitinib. Vertical error bars represent SEM. Days 0, 45, 90, 135, 180 and 225 represent the beginning of cycles 1, 2, 3, 4, 5 and 6, respectively.Back to article page